Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Tax Rate (2020 - 2026)

Cytek Biosciences filings provide 6 years of Tax Rate readings, the most recent being 993.43% for Q4 2025.

  • On a quarterly basis, Tax Rate fell 100040.0% to 993.43% in Q4 2025 year-over-year; TTM through Dec 2025 was 122.8%, a 11606.0% decrease, with the full-year FY2025 number at 122.98%, down 11736.0% from a year prior.
  • Tax Rate hit 993.43% in Q4 2025 for Cytek Biosciences, down from 29.6% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 362.39% in Q4 2021 to a low of 993.43% in Q4 2025.
  • Median Tax Rate over the past 5 years was 17.99% (2021), compared with a mean of 46.62%.
  • Biggest five-year swings in Tax Rate: surged 414275bps in 2021 and later crashed -100040bps in 2025.
  • Cytek Biosciences' Tax Rate stood at 362.39% in 2021, then crashed by -97bps to 9.63% in 2022, then tumbled by -452bps to 33.86% in 2023, then skyrocketed by 121bps to 6.97% in 2024, then crashed by -14343bps to 993.43% in 2025.
  • The last three reported values for Tax Rate were 993.43% (Q4 2025), 29.6% (Q3 2025), and 17.71% (Q2 2025) per Business Quant data.